140 related articles for article (PubMed ID: 16043736)
41. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
[TBL] [Abstract][Full Text] [Related]
42. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-200b Expression in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy.
Gomaa AR; Elsayed ET; Moftah RF
Ophthalmic Res; 2017; 58(3):168-175. PubMed ID: 28571008
[TBL] [Abstract][Full Text] [Related]
44. Lysosomal acid hydrolases in vitreous fluid of patients with proliferative diabetic retinopathy.
Nakazawa M; Tamai M
Jpn J Ophthalmol; 1991; 35(3):331-8. PubMed ID: 1770674
[TBL] [Abstract][Full Text] [Related]
45. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.
Cantón A; Burgos R; Hernández C; Mateo C; Segura RM; Mesa J; Simó R
Br J Ophthalmol; 2000 Jul; 84(7):732-5. PubMed ID: 10873984
[TBL] [Abstract][Full Text] [Related]
46. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
47. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
48. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
Yokoi M; Yamagishi S; Saito A; Yoshida Y; Matsui T; Saito W; Hirose S; Ohgami K; Kase M; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
[TBL] [Abstract][Full Text] [Related]
49. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
[TBL] [Abstract][Full Text] [Related]
50. CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis.
Cantón A; Martinez-Cáceres EM; Hernández C; Espejo C; García-Arumí J; Simó R
Arch Ophthalmol; 2004 May; 122(5):743-9. PubMed ID: 15136323
[TBL] [Abstract][Full Text] [Related]
51. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
Wu S; He X
Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
[TBL] [Abstract][Full Text] [Related]
52. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM; Kangave D; Opdenakker G
Acta Diabetol; 2013 Jun; 50(3):363-71. PubMed ID: 22864860
[TBL] [Abstract][Full Text] [Related]
53. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
54. Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.
Takeuchi M; Sato T; Sakurai Y; Taguchi M; Harimoto K; Karasawa Y; Ito M
PLoS One; 2017; 12(5):e0178230. PubMed ID: 28558009
[TBL] [Abstract][Full Text] [Related]
55. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
Petrovic MG; Korosec P; Kosnik M; Hawlina M
Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
[TBL] [Abstract][Full Text] [Related]
56. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
[TBL] [Abstract][Full Text] [Related]
57. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy.
Oku H; Kida T; Sugiyama T; Hamada J; Sato B; Ikeda T
Retina; 2001; 21(6):647-51. PubMed ID: 11756889
[TBL] [Abstract][Full Text] [Related]
58. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
[TBL] [Abstract][Full Text] [Related]
60. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
